infliximab IV - tocilizumab IV and SC - natalizumab IV - denosumab SC
Deadline
13 October 2026
Estimated Value
Not specified
Published
09 September 2026
Description
infliximab IV - tocilizumab IV en SC - natalizumab IV - denosumab SC...
🔓 Sign up free to read the full description and browse 100,000+ open tenders
Get instant access to complete tender details, deadlines, and AI-powered matching.
Create Free AccountAlready have an account? Sign in
Want AI-powered matching? Create your profile to see how well this tender matches your capabilities.